Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06357052
What this trial is testing

The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
NAFLDUrinary Lithiasis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 42
Not applicableUnknownNCT06157125
What this trial is testing

Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN

Who this might be right for
Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
Assiut University 100
Not applicableLooking for participantsNCT07149571
What this trial is testing

To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseMetabolic-associated Fatty Liver Disease
Tongji Hospital 500
Not applicableStudy completedNCT03151798
What this trial is testing

The Liver Health Study for Patients with NAFLD

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisObesity
University of Missouri-Columbia 336
Testing effectiveness (Phase 2)Study completedNCT04616014
What this trial is testing

Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Oramed, Ltd. 7
Not applicableStudy completedNCT03778411
What this trial is testing

Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.

Who this might be right for
Advanced Chronic Liver Disease, NASH
Indiana University 298
Not applicableStudy completedNCT03294850
What this trial is testing

Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery

Who this might be right for
NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease
AdventHealth Translational Research Institute 14
Testing effectiveness (Phase 2)Study completedNCT00590161
What this trial is testing

Pentoxifylline in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Case Western Reserve University 55
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Not applicableStudy completedNCT03060694
What this trial is testing

Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 58
Not applicableStudy completedNCT02647294
What this trial is testing

Polyunsaturated Fatty Acids in Patients With NAFLD.

Who this might be right for
NAFLD
General University Hospital, Prague 60
Testing effectiveness (Phase 2)Study completedNCT02653300
What this trial is testing

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)Type2 Diabetes Mellitus
Oramed, Ltd. 10
Not applicableStudy completedNCT00230087
What this trial is testing

Iron Depletion Therapy for Type 2 DM and NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 15
Not applicableStudy completedNCT06215131
What this trial is testing

Feasibility of Immersive Virtual Reality Dietician Program in Metabolic-dysfunction Associated Steatotic Liver Disease

Who this might be right for
Fatty Liver, NonalcoholicWeight LossVirtual Reality+1 more
Milton S. Hershey Medical Center 20
Not applicableUnknownNCT03749070
What this trial is testing

Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER Trial

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Camila Ribeiro de Avelar 132
Not applicableLooking for participantsNCT07270601
What this trial is testing

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseNAFLD - Non-Alcoholic Fatty Liver Disease
ContextVision AB 110
Testing effectiveness (Phase 2)Study completedNCT02217345
What this trial is testing

Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Massachusetts General Hospital 131
Not applicableUnknownNCT05734599
What this trial is testing

NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseMetabolic Disease
Huazhong University of Science and Technology 1,194
Large-scale testing (Phase 3)Study completedNCT02395900
What this trial is testing

The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT06344364
What this trial is testing

Digital Pathology and AI for Liver Outcomes in MASLD

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease
PharmaNest, Inc 1,241
Next Page